Search

everythinglearnresearchcommunity

for

Search:↓

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The dietary supplement helped increase hair growth in women with hair loss.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Early balding men may have insulin resistance, but lifestyle changes can help.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

Effective hair loss assessment requires a mix of precise measurement methods.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

A 17-year-old developed woolly hair nevus in adolescence, which is unusual, and over time the hair darkened and straightened slightly, but microscopic changes persisted.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Short anagen syndrome involves a hair growth phase lasting 1.5 years.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

High doses of finasteride cause cell growth and tumors in mice.

Mice can correct hair follicle orientation without certain genes, but proper overall alignment needs those genes.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Using finasteride with TIP extends time off period for prostate cancer patients.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Children with marasmus have more resting hair follicles and thinner, less pigmented hair, showing long-term malnutrition.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.